NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Development Talks Medication Compliance

  • 2 years ago
Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease.

Category

🗞
News

Recommended